170 related articles for article (PubMed ID: 17700721)
1. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
[TBL] [Abstract][Full Text] [Related]
2. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
Ho WS; Gardiner SM
Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Bátkai S; Pacher P; Osei-Hyiaman D; Radaeva S; Liu J; Harvey-White J; Offertáler L; Mackie K; Rudd MA; Bukoski RD; Kunos G
Circulation; 2004 Oct; 110(14):1996-2002. PubMed ID: 15451779
[TBL] [Abstract][Full Text] [Related]
5. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Silva GB; Atchison DK; Juncos LI; García NH
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
Pakdeechote P; Dunn WR; Ralevic V
Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
8. Complex regional haemodynamic effects of anandamide in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2002 Apr; 135(8):1889-96. PubMed ID: 11959791
[TBL] [Abstract][Full Text] [Related]
9. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B
J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
[TBL] [Abstract][Full Text] [Related]
10. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
Bunting MW; Widdop RE
Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
[TBL] [Abstract][Full Text] [Related]
11. Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2001 Jun; 133(3):445-53. PubMed ID: 11375262
[TBL] [Abstract][Full Text] [Related]
12. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.
Lake KD; Martin BR; Kunos G; Varga K
Hypertension; 1997 May; 29(5):1204-10. PubMed ID: 9149688
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2009 Oct; 158(4):1143-52. PubMed ID: 19702785
[TBL] [Abstract][Full Text] [Related]
15. Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor.
Li J; Kaminski NE; Wang DH
Hypertension; 2003 Mar; 41(3 Pt 2):757-62. PubMed ID: 12623992
[TBL] [Abstract][Full Text] [Related]
16. Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2002 Jun; 136(4):581-7. PubMed ID: 12055136
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
19. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.
Zakrzeska A; Schlicker E; Baranowska M; Kozłowska H; Kwolek G; Malinowska B
Br J Pharmacol; 2010 Jun; 160(3):574-84. PubMed ID: 20105178
[TBL] [Abstract][Full Text] [Related]
20. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
